This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
home:publications:mangin_days_of_molecular_medicine_2008 [12.21.2008] – paulalbert | home:publications:mangin_days_of_molecular_medicine_2008 [09.14.2022] (current) – external edit 127.0.0.1 | ||
---|---|---|---|
Line 1: | Line 1: | ||
+ | | ||
+ | {{ vimeo> | ||
+ | |||
+ | **Type:** Abstract presentation\\ | ||
+ | **Presented by:** Meg Mangin RN\\ | ||
+ | **Conference: | ||
+ | **Location: | ||
+ | **Date: | ||
+ | **Related content:** [[https:// | ||
+ | **Notes:** Meg Mangin' | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | ===== Abstract ===== | ||
+ | |||
+ | Based on this author’s experience on an NIH monitoring board, we devised and conducted a phase II clinical study of a VDR-agonist, | ||
+ | |||
+ | {{tag> | ||
+ | |||
+ | |||
+ | ===== References ===== |